nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2B6—Artemether—malaria	0.0636	0.0786	CbGbCtD
Nevirapine—CYP3A5—Artemether—malaria	0.0501	0.0619	CbGbCtD
Nevirapine—CYP3A4—Clindamycin—malaria	0.04	0.0495	CbGbCtD
Nevirapine—CYP2C9—Pyrimethamine—malaria	0.0395	0.0488	CbGbCtD
Nevirapine—CYP2C9—Sulfadiazine—malaria	0.0395	0.0488	CbGbCtD
Nevirapine—CYP2D6—Pyrimethamine—malaria	0.0362	0.0447	CbGbCtD
Nevirapine—CYP1A2—Proguanil—malaria	0.0351	0.0433	CbGbCtD
Nevirapine—CYP2B6—Quinidine—malaria	0.0339	0.0419	CbGbCtD
Nevirapine—CYP2C9—Artemether—malaria	0.0336	0.0415	CbGbCtD
Nevirapine—CYP2C9—Proguanil—malaria	0.0316	0.039	CbGbCtD
Nevirapine—CYP2D6—Artemether—malaria	0.0307	0.038	CbGbCtD
Nevirapine—CYP3A5—Quinine—malaria	0.0304	0.0375	CbGbCtD
Nevirapine—CYP2D6—Proguanil—malaria	0.0289	0.0357	CbGbCtD
Nevirapine—CYP2D6—Quinidine barbiturate—malaria	0.0274	0.0338	CbGbCtD
Nevirapine—CYP1A2—Pentoxifylline—malaria	0.0252	0.0311	CbGbCtD
Nevirapine—CYP3A5—Dapsone—malaria	0.023	0.0284	CbGbCtD
Nevirapine—CYP3A4—Sulfadiazine—malaria	0.023	0.0284	CbGbCtD
Nevirapine—CYP1A2—Quinine—malaria	0.0226	0.0279	CbGbCtD
Nevirapine—CYP2C9—Quinine—malaria	0.0204	0.0252	CbGbCtD
Nevirapine—CYP1A2—Quinidine—malaria	0.0199	0.0245	CbGbCtD
Nevirapine—CYP3A4—Artemether—malaria	0.0195	0.0241	CbGbCtD
Nevirapine—CYP2D6—Quinine—malaria	0.0186	0.023	CbGbCtD
Nevirapine—CYP3A4—Proguanil—malaria	0.0184	0.0227	CbGbCtD
Nevirapine—CYP2C9—Quinidine—malaria	0.0179	0.0221	CbGbCtD
Nevirapine—CYP3A4—Doxycycline—malaria	0.0174	0.0215	CbGbCtD
Nevirapine—CYP2D6—Quinidine—malaria	0.0164	0.0202	CbGbCtD
Nevirapine—CYP2C9—Dapsone—malaria	0.0154	0.0191	CbGbCtD
Nevirapine—CYP3A4—Quinine—malaria	0.0118	0.0146	CbGbCtD
Nevirapine—CYP3A4—Quinidine—malaria	0.0104	0.0129	CbGbCtD
Nevirapine—CYP3A4—Dapsone—malaria	0.00897	0.0111	CbGbCtD
Nevirapine—CYP1A2—blood plasma—malaria	0.00174	0.0601	CbGeAlD
Nevirapine—CYP3A5—blood plasma—malaria	0.00167	0.058	CbGeAlD
Nevirapine—CYP2B6—blood plasma—malaria	0.00166	0.0576	CbGeAlD
Nevirapine—CYP2C9—blood plasma—malaria	0.00165	0.0571	CbGeAlD
Nevirapine—Hepatobiliary disease—Proguanil—malaria	0.00126	0.00778	CcSEcCtD
Nevirapine—CYP3A4—blood plasma—malaria	0.00126	0.0435	CbGeAlD
Nevirapine—Ulcer—Clindamycin—malaria	0.00124	0.00769	CcSEcCtD
Nevirapine—Liver injury—Quinidine barbiturate—malaria	0.00124	0.00765	CcSEcCtD
Nevirapine—CYP2D6—blood plasma—malaria	0.00124	0.0428	CbGeAlD
Nevirapine—Dermatitis exfoliative—Sulfadiazine—malaria	0.00121	0.00751	CcSEcCtD
Nevirapine—Inflammation—Clindamycin—malaria	0.00121	0.0075	CcSEcCtD
Nevirapine—Skin exfoliation—Dapsone—malaria	0.00116	0.00718	CcSEcCtD
Nevirapine—Bone disorder—Quinidine barbiturate—malaria	0.00115	0.00713	CcSEcCtD
Nevirapine—Skin exfoliation—Clindamycin—malaria	0.00112	0.00694	CcSEcCtD
Nevirapine—Anaphylactic shock—Pyrimethamine—malaria	0.00109	0.00674	CcSEcCtD
Nevirapine—Immune system disorder—Proguanil—malaria	0.00108	0.00667	CcSEcCtD
Nevirapine—Rash maculo-papular—Clindamycin—malaria	0.00107	0.00661	CcSEcCtD
Nevirapine—Thrombocytopenia—Pyrimethamine—malaria	0.00107	0.0066	CcSEcCtD
Nevirapine—Hepatocellular injury—Quinidine barbiturate—malaria	0.00104	0.00644	CcSEcCtD
Nevirapine—Erythema—Proguanil—malaria	0.00104	0.00643	CcSEcCtD
Nevirapine—Anorexia—Pyrimethamine—malaria	0.00104	0.00642	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00103	0.00638	CcSEcCtD
Nevirapine—Pancreatitis—Sulfadiazine—malaria	0.000971	0.00601	CcSEcCtD
Nevirapine—CYP1A2—hematopoietic system—malaria	0.00096	0.0333	CbGeAlD
Nevirapine—Decreased appetite—Pyrimethamine—malaria	0.000947	0.00586	CcSEcCtD
Nevirapine—CYP2A6—liver—malaria	0.000947	0.0328	CbGeAlD
Nevirapine—CYP3A5—hematopoietic system—malaria	0.000926	0.0321	CbGeAlD
Nevirapine—CYP2B6—hematopoietic system—malaria	0.00092	0.0319	CbGeAlD
Nevirapine—CYP2C9—hematopoietic system—malaria	0.000911	0.0316	CbGeAlD
Nevirapine—Dermatitis exfoliative—Clindamycin—malaria	0.000905	0.00559	CcSEcCtD
Nevirapine—Dermatitis bullous—Clindamycin—malaria	0.000893	0.00552	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Quinine—malaria	0.000887	0.00549	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Quinidine—malaria	0.000887	0.00549	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000879	0.00544	CcSEcCtD
Nevirapine—Dermatitis bullous—Quinidine—malaria	0.000876	0.00542	CcSEcCtD
Nevirapine—Dermatitis bullous—Quinine—malaria	0.000876	0.00542	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.000876	0.00541	CcSEcCtD
Nevirapine—Neuropathy peripheral—Sulfadiazine—malaria	0.000866	0.00535	CcSEcCtD
Nevirapine—Nervous system disorder—Proguanil—malaria	0.000832	0.00515	CcSEcCtD
Nevirapine—Skin disorder—Proguanil—malaria	0.000824	0.0051	CcSEcCtD
Nevirapine—Agranulocytosis—Sulfadiazine—malaria	0.000824	0.0051	CcSEcCtD
Nevirapine—Anorexia—Proguanil—malaria	0.000809	0.005	CcSEcCtD
Nevirapine—Hypersensitivity—Pyrimethamine—malaria	0.000803	0.00496	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Quinidine barbiturate—malaria	0.000801	0.00495	CcSEcCtD
Nevirapine—Hepatitis—Sulfadiazine—malaria	0.000793	0.0049	CcSEcCtD
Nevirapine—Dermatitis bullous—Quinidine barbiturate—malaria	0.000791	0.00489	CcSEcCtD
Nevirapine—Liver function test abnormal—Quinidine—malaria	0.000773	0.00478	CcSEcCtD
Nevirapine—Liver function test abnormal—Quinine—malaria	0.000773	0.00478	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Clindamycin—malaria	0.000769	0.00475	CcSEcCtD
Nevirapine—CYP3A5—kidney—malaria	0.000759	0.0263	CbGeAlD
Nevirapine—CYP2B6—kidney—malaria	0.000754	0.0261	CbGeAlD
Nevirapine—Toxic epidermal necrolysis—Quinine—malaria	0.000754	0.00466	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Quinidine—malaria	0.000754	0.00466	CcSEcCtD
Nevirapine—CYP2A6—brain—malaria	0.000751	0.026	CbGeAlD
Nevirapine—Erythema multiforme—Sulfadiazine—malaria	0.00075	0.00464	CcSEcCtD
Nevirapine—Pancreatitis—Dapsone—malaria	0.000748	0.00462	CcSEcCtD
Nevirapine—Decreased appetite—Proguanil—malaria	0.000738	0.00456	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Proguanil—malaria	0.000733	0.00453	CcSEcCtD
Nevirapine—Eosinophilia—Clindamycin—malaria	0.00073	0.00452	CcSEcCtD
Nevirapine—Liver function test abnormal—Quinidine barbiturate—malaria	0.000698	0.00431	CcSEcCtD
Nevirapine—CYP3A4—hematopoietic system—malaria	0.000695	0.0241	CbGeAlD
Nevirapine—Gastrointestinal pain—Proguanil—malaria	0.000694	0.00429	CcSEcCtD
Nevirapine—Vomiting—Pyrimethamine—malaria	0.000693	0.00428	CcSEcCtD
Nevirapine—Neutropenia—Clindamycin—malaria	0.00069	0.00427	CcSEcCtD
Nevirapine—CYP2D6—hematopoietic system—malaria	0.000684	0.0237	CbGeAlD
Nevirapine—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.000681	0.00421	CcSEcCtD
Nevirapine—Neutropenia—Quinidine—malaria	0.000677	0.00418	CcSEcCtD
Nevirapine—Neutropenia—Quinine—malaria	0.000677	0.00418	CcSEcCtD
Nevirapine—Body temperature increased—Proguanil—malaria	0.000671	0.00415	CcSEcCtD
Nevirapine—Abdominal pain—Proguanil—malaria	0.000671	0.00415	CcSEcCtD
Nevirapine—CYP1A2—digestive system—malaria	0.000667	0.0231	CbGeAlD
Nevirapine—Neuropathy peripheral—Dapsone—malaria	0.000667	0.00412	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Clindamycin—malaria	0.000652	0.00403	CcSEcCtD
Nevirapine—CYP3A5—digestive system—malaria	0.000644	0.0223	CbGeAlD
Nevirapine—Jaundice—Clindamycin—malaria	0.000641	0.00396	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Quinidine—malaria	0.00064	0.00396	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Quinine—malaria	0.00064	0.00396	CcSEcCtD
Nevirapine—CYP2B6—digestive system—malaria	0.00064	0.0222	CbGeAlD
Nevirapine—CYP1A2—blood—malaria	0.000636	0.022	CbGeAlD
Nevirapine—Renal failure—Quinidine—malaria	0.000634	0.00392	CcSEcCtD
Nevirapine—Renal failure—Quinine—malaria	0.000634	0.00392	CcSEcCtD
Nevirapine—CYP2C9—digestive system—malaria	0.000634	0.022	CbGeAlD
Nevirapine—Jaundice—Quinidine—malaria	0.000629	0.00389	CcSEcCtD
Nevirapine—Jaundice—Quinine—malaria	0.000629	0.00389	CcSEcCtD
Nevirapine—Agranulocytosis—Clindamycin—malaria	0.000614	0.0038	CcSEcCtD
Nevirapine—CYP3A5—blood—malaria	0.000613	0.0212	CbGeAlD
Nevirapine—Neutropenia—Quinidine barbiturate—malaria	0.000611	0.00378	CcSEcCtD
Nevirapine—CYP2B6—blood—malaria	0.00061	0.0211	CbGeAlD
Nevirapine—CYP2C9—blood—malaria	0.000604	0.0209	CbGeAlD
Nevirapine—Agranulocytosis—Quinidine—malaria	0.000602	0.00372	CcSEcCtD
Nevirapine—Agranulocytosis—Quinine—malaria	0.000602	0.00372	CcSEcCtD
Nevirapine—Arthralgia—Sulfadiazine—malaria	0.000588	0.00363	CcSEcCtD
Nevirapine—Diarrhoea—Proguanil—malaria	0.000581	0.00359	CcSEcCtD
Nevirapine—Hepatitis—Quinidine—malaria	0.000579	0.00358	CcSEcCtD
Nevirapine—Hepatitis—Quinine—malaria	0.000579	0.00358	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000577	0.00357	CcSEcCtD
Nevirapine—Renal failure—Quinidine barbiturate—malaria	0.000573	0.00354	CcSEcCtD
Nevirapine—CYP3A4—kidney—malaria	0.000569	0.0197	CbGeAlD
Nevirapine—Jaundice—Quinidine barbiturate—malaria	0.000568	0.00351	CcSEcCtD
Nevirapine—Jaundice—Pentoxifylline—malaria	0.000567	0.0035	CcSEcCtD
Nevirapine—Conjunctivitis—Pentoxifylline—malaria	0.000565	0.00349	CcSEcCtD
Nevirapine—Anaphylactic shock—Sulfadiazine—malaria	0.000563	0.00348	CcSEcCtD
Nevirapine—CYP2D6—kidney—malaria	0.00056	0.0194	CbGeAlD
Nevirapine—Erythema multiforme—Clindamycin—malaria	0.000558	0.00345	CcSEcCtD
Nevirapine—Thrombocytopenia—Sulfadiazine—malaria	0.000552	0.00341	CcSEcCtD
Nevirapine—Hepatobiliary disease—Pentoxifylline—malaria	0.00055	0.0034	CcSEcCtD
Nevirapine—Erythema multiforme—Quinidine—malaria	0.000548	0.00339	CcSEcCtD
Nevirapine—Erythema multiforme—Quinine—malaria	0.000548	0.00339	CcSEcCtD
Nevirapine—Agranulocytosis—Quinidine barbiturate—malaria	0.000543	0.00336	CcSEcCtD
Nevirapine—Vomiting—Proguanil—malaria	0.00054	0.00334	CcSEcCtD
Nevirapine—Anorexia—Sulfadiazine—malaria	0.000537	0.00332	CcSEcCtD
Nevirapine—Rash—Proguanil—malaria	0.000535	0.00331	CcSEcCtD
Nevirapine—Dermatitis—Proguanil—malaria	0.000535	0.00331	CcSEcCtD
Nevirapine—Headache—Proguanil—malaria	0.000532	0.00329	CcSEcCtD
Nevirapine—Erythema—Dapsone—malaria	0.000531	0.00329	CcSEcCtD
Nevirapine—Immune system disorder—Quinine—malaria	0.000523	0.00324	CcSEcCtD
Nevirapine—Immune system disorder—Quinidine—malaria	0.000523	0.00324	CcSEcCtD
Nevirapine—Hepatitis—Quinidine barbiturate—malaria	0.000523	0.00323	CcSEcCtD
Nevirapine—Hepatitis—Pentoxifylline—malaria	0.000522	0.00323	CcSEcCtD
Nevirapine—Erythema—Clindamycin—malaria	0.000514	0.00318	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000513	0.00317	CcSEcCtD
Nevirapine—Erythema—Quinine—malaria	0.000504	0.00312	CcSEcCtD
Nevirapine—Erythema—Quinidine—malaria	0.000504	0.00312	CcSEcCtD
Nevirapine—Nausea—Proguanil—malaria	0.000504	0.00312	CcSEcCtD
Nevirapine—CYP1A2—liver—malaria	0.000497	0.0172	CbGeAlD
Nevirapine—Erythema multiforme—Quinidine barbiturate—malaria	0.000494	0.00306	CcSEcCtD
Nevirapine—Decreased appetite—Sulfadiazine—malaria	0.00049	0.00303	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Sulfadiazine—malaria	0.000486	0.00301	CcSEcCtD
Nevirapine—CYP3A4—digestive system—malaria	0.000483	0.0167	CbGeAlD
Nevirapine—CYP3A5—liver—malaria	0.00048	0.0166	CbGeAlD
Nevirapine—CYP2B6—liver—malaria	0.000477	0.0165	CbGeAlD
Nevirapine—CYP2D6—digestive system—malaria	0.000475	0.0165	CbGeAlD
Nevirapine—Anaemia—Clindamycin—malaria	0.000475	0.00294	CcSEcCtD
Nevirapine—Immune system disorder—Quinidine barbiturate—malaria	0.000472	0.00292	CcSEcCtD
Nevirapine—CYP2C9—liver—malaria	0.000472	0.0164	CbGeAlD
Nevirapine—Immune system disorder—Pentoxifylline—malaria	0.000471	0.00291	CcSEcCtD
Nevirapine—Angioedema—Quinidine—malaria	0.000461	0.00285	CcSEcCtD
Nevirapine—Angioedema—Quinine—malaria	0.000461	0.00285	CcSEcCtD
Nevirapine—Gastrointestinal pain—Sulfadiazine—malaria	0.000461	0.00285	CcSEcCtD
Nevirapine—CYP3A4—blood—malaria	0.00046	0.0159	CbGeAlD
Nevirapine—Erythema—Quinidine barbiturate—malaria	0.000455	0.00281	CcSEcCtD
Nevirapine—Erythema—Pentoxifylline—malaria	0.000454	0.00281	CcSEcCtD
Nevirapine—CYP2D6—blood—malaria	0.000453	0.0157	CbGeAlD
Nevirapine—Urticaria—Sulfadiazine—malaria	0.000448	0.00277	CcSEcCtD
Nevirapine—Body temperature increased—Sulfadiazine—malaria	0.000445	0.00275	CcSEcCtD
Nevirapine—Abdominal pain—Sulfadiazine—malaria	0.000445	0.00275	CcSEcCtD
Nevirapine—Discomfort—Clindamycin—malaria	0.000432	0.00267	CcSEcCtD
Nevirapine—Myalgia—Quinidine—malaria	0.000429	0.00265	CcSEcCtD
Nevirapine—Myalgia—Quinine—malaria	0.000429	0.00265	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000426	0.00264	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000426	0.00264	CcSEcCtD
Nevirapine—Ill-defined disorder—Pentoxifylline—malaria	0.000422	0.00261	CcSEcCtD
Nevirapine—Anaemia—Pentoxifylline—malaria	0.00042	0.0026	CcSEcCtD
Nevirapine—Anaphylactic shock—Clindamycin—malaria	0.00042	0.00259	CcSEcCtD
Nevirapine—Angioedema—Quinidine barbiturate—malaria	0.000416	0.00257	CcSEcCtD
Nevirapine—Angioedema—Pentoxifylline—malaria	0.000415	0.00257	CcSEcCtD
Nevirapine—Hypersensitivity—Sulfadiazine—malaria	0.000415	0.00257	CcSEcCtD
Nevirapine—Oedema—Quinidine—malaria	0.000412	0.00254	CcSEcCtD
Nevirapine—Oedema—Quinine—malaria	0.000412	0.00254	CcSEcCtD
Nevirapine—Thrombocytopenia—Clindamycin—malaria	0.000411	0.00254	CcSEcCtD
Nevirapine—Malaise—Pentoxifylline—malaria	0.00041	0.00253	CcSEcCtD
Nevirapine—Nervous system disorder—Quinidine—malaria	0.000404	0.0025	CcSEcCtD
Nevirapine—Nervous system disorder—Quinine—malaria	0.000404	0.0025	CcSEcCtD
Nevirapine—Thrombocytopenia—Quinidine—malaria	0.000403	0.00249	CcSEcCtD
Nevirapine—Thrombocytopenia—Quinine—malaria	0.000403	0.00249	CcSEcCtD
Nevirapine—Skin disorder—Quinidine—malaria	0.0004	0.00247	CcSEcCtD
Nevirapine—Skin disorder—Quinine—malaria	0.0004	0.00247	CcSEcCtD
Nevirapine—Pruritus—Sulfadiazine—malaria	0.000399	0.00246	CcSEcCtD
Nevirapine—Anorexia—Quinine—malaria	0.000392	0.00243	CcSEcCtD
Nevirapine—Anorexia—Quinidine—malaria	0.000392	0.00243	CcSEcCtD
Nevirapine—Myalgia—Quinidine barbiturate—malaria	0.000387	0.0024	CcSEcCtD
Nevirapine—Arthralgia—Quinidine barbiturate—malaria	0.000387	0.0024	CcSEcCtD
Nevirapine—Myalgia—Pentoxifylline—malaria	0.000387	0.00239	CcSEcCtD
Nevirapine—Diarrhoea—Sulfadiazine—malaria	0.000385	0.00238	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000385	0.00238	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000384	0.00237	CcSEcCtD
Nevirapine—Discomfort—Pentoxifylline—malaria	0.000382	0.00236	CcSEcCtD
Nevirapine—CYP2B6—brain—malaria	0.000378	0.0131	CbGeAlD
Nevirapine—Musculoskeletal discomfort—Quinidine—malaria	0.000375	0.00232	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Quinine—malaria	0.000375	0.00232	CcSEcCtD
Nevirapine—Oedema—Quinidine barbiturate—malaria	0.000371	0.0023	CcSEcCtD
Nevirapine—Anaphylactic shock—Pentoxifylline—malaria	0.000371	0.00229	CcSEcCtD
Nevirapine—Oedema—Pentoxifylline—malaria	0.000371	0.00229	CcSEcCtD
Nevirapine—Nervous system disorder—Quinidine barbiturate—malaria	0.000364	0.00225	CcSEcCtD
Nevirapine—Thrombocytopenia—Quinidine barbiturate—malaria	0.000364	0.00225	CcSEcCtD
Nevirapine—Thrombocytopenia—Pentoxifylline—malaria	0.000363	0.00224	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Clindamycin—malaria	0.000362	0.00224	CcSEcCtD
Nevirapine—Fatigue—Clindamycin—malaria	0.000362	0.00224	CcSEcCtD
Nevirapine—Skin disorder—Quinidine barbiturate—malaria	0.000361	0.00223	CcSEcCtD
Nevirapine—Skin disorder—Pentoxifylline—malaria	0.00036	0.00223	CcSEcCtD
Nevirapine—CYP3A4—liver—malaria	0.00036	0.0125	CbGeAlD
Nevirapine—Pain—Clindamycin—malaria	0.000359	0.00222	CcSEcCtD
Nevirapine—Vomiting—Sulfadiazine—malaria	0.000358	0.00221	CcSEcCtD
Nevirapine—Decreased appetite—Quinidine—malaria	0.000358	0.00221	CcSEcCtD
Nevirapine—Decreased appetite—Quinine—malaria	0.000358	0.00221	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Quinine—malaria	0.000355	0.0022	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Quinidine—malaria	0.000355	0.0022	CcSEcCtD
Nevirapine—Rash—Sulfadiazine—malaria	0.000355	0.0022	CcSEcCtD
Nevirapine—Dermatitis—Sulfadiazine—malaria	0.000355	0.00219	CcSEcCtD
Nevirapine—Gastrointestinal pain—Dapsone—malaria	0.000355	0.00219	CcSEcCtD
Nevirapine—CYP2D6—liver—malaria	0.000354	0.0123	CbGeAlD
Nevirapine—Anorexia—Quinidine barbiturate—malaria	0.000354	0.00219	CcSEcCtD
Nevirapine—Anorexia—Pentoxifylline—malaria	0.000353	0.00219	CcSEcCtD
Nevirapine—Headache—Sulfadiazine—malaria	0.000353	0.00218	CcSEcCtD
Nevirapine—Gastrointestinal pain—Clindamycin—malaria	0.000343	0.00212	CcSEcCtD
Nevirapine—Body temperature increased—Dapsone—malaria	0.000343	0.00212	CcSEcCtD
Nevirapine—Abdominal pain—Dapsone—malaria	0.000343	0.00212	CcSEcCtD
Nevirapine—Feeling abnormal—Quinidine—malaria	0.000339	0.0021	CcSEcCtD
Nevirapine—Feeling abnormal—Quinine—malaria	0.000339	0.0021	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000338	0.00209	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000338	0.00209	CcSEcCtD
Nevirapine—Gastrointestinal pain—Quinidine—malaria	0.000337	0.00208	CcSEcCtD
Nevirapine—Gastrointestinal pain—Quinine—malaria	0.000337	0.00208	CcSEcCtD
Nevirapine—Nausea—Sulfadiazine—malaria	0.000335	0.00207	CcSEcCtD
Nevirapine—Urticaria—Clindamycin—malaria	0.000333	0.00206	CcSEcCtD
Nevirapine—Abdominal pain—Clindamycin—malaria	0.000332	0.00205	CcSEcCtD
Nevirapine—Body temperature increased—Clindamycin—malaria	0.000332	0.00205	CcSEcCtD
Nevirapine—Somnolence—Quinidine barbiturate—malaria	0.00033	0.00204	CcSEcCtD
Nevirapine—Somnolence—Pentoxifylline—malaria	0.00033	0.00204	CcSEcCtD
Nevirapine—Urticaria—Quinine—malaria	0.000327	0.00202	CcSEcCtD
Nevirapine—Urticaria—Quinidine—malaria	0.000327	0.00202	CcSEcCtD
Nevirapine—Abdominal pain—Quinine—malaria	0.000325	0.00201	CcSEcCtD
Nevirapine—Body temperature increased—Quinine—malaria	0.000325	0.00201	CcSEcCtD
Nevirapine—Body temperature increased—Quinidine—malaria	0.000325	0.00201	CcSEcCtD
Nevirapine—Abdominal pain—Quinidine—malaria	0.000325	0.00201	CcSEcCtD
Nevirapine—Decreased appetite—Quinidine barbiturate—malaria	0.000323	0.002	CcSEcCtD
Nevirapine—Decreased appetite—Pentoxifylline—malaria	0.000322	0.00199	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000321	0.00198	CcSEcCtD
Nevirapine—Pain—Quinidine barbiturate—malaria	0.000318	0.00196	CcSEcCtD
Nevirapine—Hypersensitivity—Clindamycin—malaria	0.000309	0.00191	CcSEcCtD
Nevirapine—Feeling abnormal—Quinidine barbiturate—malaria	0.000306	0.00189	CcSEcCtD
Nevirapine—Feeling abnormal—Pentoxifylline—malaria	0.000306	0.00189	CcSEcCtD
Nevirapine—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000304	0.00188	CcSEcCtD
Nevirapine—Hypersensitivity—Quinidine—malaria	0.000303	0.00187	CcSEcCtD
Nevirapine—Hypersensitivity—Quinine—malaria	0.000303	0.00187	CcSEcCtD
Nevirapine—Gastrointestinal pain—Pentoxifylline—malaria	0.000303	0.00187	CcSEcCtD
Nevirapine—Asthenia—Clindamycin—malaria	0.000301	0.00186	CcSEcCtD
Nevirapine—Pruritus—Clindamycin—malaria	0.000297	0.00184	CcSEcCtD
Nevirapine—Asthenia—Quinidine—malaria	0.000295	0.00183	CcSEcCtD
Nevirapine—Asthenia—Quinine—malaria	0.000295	0.00183	CcSEcCtD
Nevirapine—Urticaria—Quinidine barbiturate—malaria	0.000295	0.00182	CcSEcCtD
Nevirapine—Urticaria—Pentoxifylline—malaria	0.000295	0.00182	CcSEcCtD
Nevirapine—Abdominal pain—Quinidine barbiturate—malaria	0.000294	0.00182	CcSEcCtD
Nevirapine—Body temperature increased—Quinidine barbiturate—malaria	0.000294	0.00182	CcSEcCtD
Nevirapine—Abdominal pain—Pentoxifylline—malaria	0.000293	0.00181	CcSEcCtD
Nevirapine—Body temperature increased—Pentoxifylline—malaria	0.000293	0.00181	CcSEcCtD
Nevirapine—Pruritus—Quinidine—malaria	0.000291	0.0018	CcSEcCtD
Nevirapine—Pruritus—Quinine—malaria	0.000291	0.0018	CcSEcCtD
Nevirapine—Diarrhoea—Clindamycin—malaria	0.000287	0.00177	CcSEcCtD
Nevirapine—Diarrhoea—Quinidine—malaria	0.000282	0.00174	CcSEcCtD
Nevirapine—Diarrhoea—Quinine—malaria	0.000282	0.00174	CcSEcCtD
Nevirapine—CYP2D6—brain—malaria	0.000281	0.00974	CbGeAlD
Nevirapine—Vomiting—Dapsone—malaria	0.000276	0.00171	CcSEcCtD
Nevirapine—Hypersensitivity—Quinidine barbiturate—malaria	0.000274	0.00169	CcSEcCtD
Nevirapine—Hypersensitivity—Pentoxifylline—malaria	0.000273	0.00169	CcSEcCtD
Nevirapine—Headache—Dapsone—malaria	0.000272	0.00168	CcSEcCtD
Nevirapine—Vomiting—Clindamycin—malaria	0.000267	0.00165	CcSEcCtD
Nevirapine—Asthenia—Quinidine barbiturate—malaria	0.000267	0.00165	CcSEcCtD
Nevirapine—Asthenia—Pentoxifylline—malaria	0.000266	0.00164	CcSEcCtD
Nevirapine—Rash—Clindamycin—malaria	0.000265	0.00164	CcSEcCtD
Nevirapine—Dermatitis—Clindamycin—malaria	0.000264	0.00163	CcSEcCtD
Nevirapine—Headache—Clindamycin—malaria	0.000263	0.00163	CcSEcCtD
Nevirapine—Pruritus—Quinidine barbiturate—malaria	0.000263	0.00162	CcSEcCtD
Nevirapine—Pruritus—Pentoxifylline—malaria	0.000262	0.00162	CcSEcCtD
Nevirapine—Vomiting—Quinine—malaria	0.000262	0.00162	CcSEcCtD
Nevirapine—Vomiting—Quinidine—malaria	0.000262	0.00162	CcSEcCtD
Nevirapine—Rash—Quinidine—malaria	0.00026	0.0016	CcSEcCtD
Nevirapine—Rash—Quinine—malaria	0.00026	0.0016	CcSEcCtD
Nevirapine—Dermatitis—Quinidine—malaria	0.000259	0.0016	CcSEcCtD
Nevirapine—Dermatitis—Quinine—malaria	0.000259	0.0016	CcSEcCtD
Nevirapine—Headache—Quinine—malaria	0.000258	0.00159	CcSEcCtD
Nevirapine—Headache—Quinidine—malaria	0.000258	0.00159	CcSEcCtD
Nevirapine—Nausea—Dapsone—malaria	0.000258	0.00159	CcSEcCtD
Nevirapine—Diarrhoea—Quinidine barbiturate—malaria	0.000254	0.00157	CcSEcCtD
Nevirapine—Diarrhoea—Pentoxifylline—malaria	0.000254	0.00157	CcSEcCtD
Nevirapine—Nausea—Clindamycin—malaria	0.000249	0.00154	CcSEcCtD
Nevirapine—Nausea—Quinine—malaria	0.000244	0.00151	CcSEcCtD
Nevirapine—Nausea—Quinidine—malaria	0.000244	0.00151	CcSEcCtD
Nevirapine—Vomiting—Quinidine barbiturate—malaria	0.000236	0.00146	CcSEcCtD
Nevirapine—Vomiting—Pentoxifylline—malaria	0.000236	0.00146	CcSEcCtD
Nevirapine—Rash—Quinidine barbiturate—malaria	0.000234	0.00145	CcSEcCtD
Nevirapine—Dermatitis—Quinidine barbiturate—malaria	0.000234	0.00145	CcSEcCtD
Nevirapine—Rash—Pentoxifylline—malaria	0.000234	0.00145	CcSEcCtD
Nevirapine—Dermatitis—Pentoxifylline—malaria	0.000234	0.00144	CcSEcCtD
Nevirapine—Headache—Quinidine barbiturate—malaria	0.000233	0.00144	CcSEcCtD
Nevirapine—Headache—Pentoxifylline—malaria	0.000232	0.00144	CcSEcCtD
Nevirapine—Nausea—Quinidine barbiturate—malaria	0.000221	0.00136	CcSEcCtD
Nevirapine—Nausea—Pentoxifylline—malaria	0.00022	0.00136	CcSEcCtD
